Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/33782
Type
ArticleCopyright
Open access
Collections
- IOC - Artigos de Periódicos [12978]
Metadata
Show full item record
DRUG-RESISTANCE IN LEPROSY: MOVING TOWARD UNDERSTANDING THE SCOPE OF THE PROBLEM AND HOW TO TACKLE IT
Moraes, Milton Ozório | Date Issued:
2016
Author
Affilliation
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hanseníase. Rio de Janeiro, RJ. Brasil.
Abstract
Leprosy is an infectious disease caused by Mycobacterium leprae, a bacterium that infects Schwann cells in the peripheral nervous system and macrophages in the skin. Leprosy presents primarily as a peripheral neuropathy but may lead to deformities if it progresses without treatment. Leprosy cases are classified as paucibacillary if the patient has 5 or fewer skin lesions and low bacterial counts or as multibacillary if the patient has more than 5 lesions and high bacterial counts. The complexity of clinical presentations has hindered the development of an easy diagnostic test.
Share